Composites Part B Engineering, Год журнала: 2024, Номер 289, С. 111944 - 111944
Опубликована: Ноя. 5, 2024
Язык: Английский
Composites Part B Engineering, Год журнала: 2024, Номер 289, С. 111944 - 111944
Опубликована: Ноя. 5, 2024
Язык: Английский
Life Sciences, Год журнала: 2025, Номер 368, С. 123499 - 123499
Опубликована: Фев. 22, 2025
Язык: Английский
Процитировано
1European Respiratory Journal, Год журнала: 2025, Номер 65(1), С. 2402194 - 2402194
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0International Journal of Nanomedicine, Год журнала: 2025, Номер Volume 20, С. 2521 - 2553
Опубликована: Фев. 1, 2025
Exosomes (Exos) derived from human umbilical cord mesenchymal stem cells (hUC-MSCs) hold great potential for treating bronchopulmonary dysplasia (BPD); however, safety concerns and effects of intranasal administration remain unexplored. This study aimed to explore the hUC-MSCs Exos investigate efficacy bio-distribution repeated in neonatal BPD models. Characteristics were analyzed. A subcutaneous tumor formation assay using a single dose or was conducted Crl:NU-Foxn1nu mice. Vital signs, biochemical indices, pathological alterations, 18F-FDG microPET/CT analysis examined. Pulmonary pathology, three-dimensional reconstructions, ultrastructural structures, vivo ex imaging analyses, enzyme-linked immunoassay assays, reverse transcription-quantitative polymerase chain reaction analyses lung tissues all documented following administration. satisfied specifications. mice did not exhibit overt toxicity carcinogenicity after 60 days observation. Repeated effectively alleviated injuries, restored pulmonary ventilation reconstruction, recovered endothelial cell layer integrity analysis. steadily accumulated postnatal day 1 14. also interrupted epithelial-mesenchymal transition inflammation reactions As nanoscale, non-cellular therapy, an effective, noninvasive treatment BPD. approach free toxic, tumorigenic risks repaired alveolar damage while interrupting with
Язык: Английский
Процитировано
0International Journal of Molecular Sciences, Год журнала: 2024, Номер 26(1), С. 225 - 225
Опубликована: Дек. 30, 2024
The global issue of aging populations has become increasingly prominent, thus the research and development for anti-aging therapies to assure longevity as well ameliorate age-related complications is put high on agenda. young humoral milieu been substantiated impart youthful characteristics aged cells or organs. Extracellular vesicles (EVs) are a heterogeneous group cell-derived membrane-limited structures that serve couriers proteins genetic material regulate intercellular communication. Of note, EVs appeared be an indispensable component blood in prolonging lifespans, circulating have indicated mediate beneficial effect aging. Human umbilical cord mesenchymal stem (HUCMSC-EVs), isolated from youngest adult cell source, speculated reproduce function partially revitalize numerous organs old animals. Robust evidence suggested HUCMSC-EVs muti-target therapeutic agents combating alleviating degenerative disorders. Here, we provide comprehensive overview effects brain, heart, vasculature, kidney, muscle, bone, other Furthermore, critically discuss current investigation engineering strategies HUCMSC-EVs, intending unveil their full potential field research.
Язык: Английский
Процитировано
2Composites Part B Engineering, Год журнала: 2024, Номер 289, С. 111944 - 111944
Опубликована: Ноя. 5, 2024
Язык: Английский
Процитировано
1